News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Aphios Granted United States Patent for Zindol



3/4/2013 9:51:30 AM

WOBURN, Mass.--(BUSINESS WIRE)--Aphios Corporation today announced that it received notification of allowance for a United States Patent entitled “Use of Gingerols for Cancer Patients Suffering from Nausea and Emesis Induced by Chemotherapy.” Despite the widespread use of 5-HT3 receptor antagonist anti-emetics such as Palonosetron (Aloxi; Eisai), chemotherapy induced nausea continues to be reported by 70% of adult patients and 58% of children receiving highly emetogenic chemotherapy. Furthermore, these anti-emetics are associated with significant adverse effects such as sedation, extra-pyramidal side effects and hypotension as well as headache, diarrhea and constipation. A desirable attribute in any substitute or additional anti-emetic medication is the absence of clinically significant adverse effects.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES